News > Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 treatment

Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 treatment

Zydus Cadila on Monday informed that it has sought approval of the DGCI for using its hepatitis drug for the treatment of coronavirus.

"In what could be a breakthrough in the disease management of COVID-19, the interim results indicate that PegIFN when administered early on, could help patients recover faster".